Read articles from Global

March 18, 2026 by substack.com

Complementing and expanding Chris Snowdon's latest Substack on passive vaping

This is the second post (see first post) complementing and expanding the excellent Substack by Chris Snowdon on the weakness of evidence against risks of “passive vaping” (exposure to “second hand” or the aerosol exhaled by vapers). This Substack post continues my previous critique of studies mentioned by Chris. I will examine what happens under special conditions with multiple vapers producing a large mass of exhaled vaping aerosol (EVA). [...]

March 17, 2026 by thefp.com

Flavored Vapes Can Save Lives

Last week, the Food and Drug Administration quietly released the results of its annual youth tobacco survey, revealing a significant public health achievement. The data showed a dramatic decline in vaping among high school students, dropping from nearly 30 percent in 2019 to just 5.2 percent in 2025. Even more striking, only 1.4 percent of high school students reported smoking, meaning just over one percent still use traditional cigarettes. Despite this remarkable progress, which could be considered one of the greatest successes in public health history, organizations such as the Campaign for Tobacco-Free Kids, the American Lung Association, and the FDA are focusing their attention on the debate over whether flavored e-cigarettes should be permitted, rather than celebrating the overall decline in youth tobacco use.

March 17, 2026 by filtermag.org

The Youth-Smoking Collapse Nobody Wants to Talk About

The tobacco control claim that nicotine vapes act as a gateway to smoking for young people is debunked by the latest National Youth Tobacco Survey (NYTS) in the US. Data from 2025 shows declining tobacco and nicotine use among youth, with daily smoking almost disappearing. Observational studies supporting the gateway theory lack causal evidence, as youth smoking rates have decreased while vaping became more common. Despite these positive trends, public health authorities continue to mislead about vaping's impact on smoking. Acknowledging the success in reducing youth smoking requires honest interpretation of data. It's crucial for health institutions to update their messaging to align with current evidence.

March 17, 2026 by gfn.tv

GFN News #182 | CAN VAPING AND SUSTAINABILITY COEXIST?

In this episode, we unpack the hidden environmental cost of vaping - from millions of discarded devices and batteries to ecosystem contamination - and why awareness isn’t translating into action. The conversation highlights a major gap: many users recognize the harm, but far fewer know how (or where) to recycle, and only a minority actually do. We also explore what could change the outcome: clearer product labeling, education that’s practical (not fear-based), better recycling infrastructure, and shared responsibility between governments, manufacturers, retailers, and users—moving toward a circular-economy approach to nicotine products.

March 17, 2026 by gfn.tv

GFN News #181 | CIRCULAR VAPE RECYCLING AND THE FUTURE OF SUSTAINABLE THR

In this GFN News interview, Aylen Van Isseldyk (creator of the global research project Circular Vape Recycling) explains the hidden environmental impact of vaping devices—from hard-to-degrade plastics and lithium batteries to the structural barriers that make e-cigarette recycling so difficult. ​ We also discuss why awareness alone isn’t enough, what manufacturers and institutions can do (eco-design, modular/reusable devices, and extended producer responsibility), and how users can help by returning devices to collection points and choosing more sustainable options.

March 16, 2026 by gfn.tv

GFN News #180 | #GFN26 APPROACHING! | Prohibition, Public Health and the Future of Safer Nicotine

Join us at the Global Forum on Nicotine 2026 in Warsaw and be part of the only truly open conference on safer nicotine, tobacco harm reduction and the real impacts of prohibition on public health. Hear leading scientists, clinicians, ethicists and advocates discuss social, health and economic consequences of bans, explore strategies to reach marginalized groups, and discover the latest research in our popular Science Lab sessions. Keynotes from pioneers like Dr Alex Wodak and other international experts, plus multilingual streaming and a dedicated Spanish-language session, make GFN 2026 a must-attend event for anyone serious about nicotine policy and harm reduction. ​ Ready to join the discussion? Visit GFN.EVENTS to register!

March 16, 2026 by theconversation.com

Vaping: emerging harms health systems can’t ignore

E-cigarettes appeared around 2010 and were initially seen as a safer alternative to traditional cigarettes because they deliver nicotine without toxic tar and combustion products. Public health organizations even supported them as a possible tool to help adult smokers quit. Early research suggested that vaping could be about 95% less harmful than smoking. However, after more than a decade the safety of vaping is less certain. A recent study found that people who vape or smoke have nearly 50% higher odds of having elevated blood pressure than non-users, although other lifestyle factors may also influence the results.

March 13, 2026 by planetofthevapes.co.uk

“Myths vs Facts” Ignores Success

The World Health Organization’s (WHO) Framework Convention on Tobacco Control’s (FCTC) new social media “Myths vs Facts" series on X/Twitter ignores real-world tobacco harm reduction success, says the Coalition of Asia Pacific Tobacco Harm Reduction Advocates. The consumer advocacy organisation says it is time for them to embrace the evidence.

March 12, 2026 by planetofthevapes.co.uk

Lords Debate Vape Bill

Lords debated the Tobacco and Vapes Bill in the House of Lords on the first day of Report stage – with Action on Smoking and Health calling it “a significant moment for public health”.

March 11, 2026 by jamanetwork.com

Psilocybin or Nicotine Patch for Smoking Cessation - A Pilot Randomized Clinical Trial

What tobacco smoking cessation rates does psilocybin, an experimental treatment, yield compared with nicotine patch, an established treatment, with individuals in both groups receiving standardized cognitive behavioral therapy? In a randomized clinical trial, 42 participants randomized to receive psilocybin had more than 6 times greater odds of prolonged smoking abstinence 6 months after treatment than 40 participants who received the nicotine patch. The results suggest that psilocybin holds potential in the treatment of tobacco use disorder and, along with other psychedelics, should be investigated further for tobacco and other substance use disorders.